A new study from King's College London shows that off-label prescriptions of a common antidepressant doesn't help breathlessness in patients with respiratory disease – and may cause side effects.
Researchers warn prescribing medicines for a use which it has not been licensed could make things worse, even though the prescriber was trying to help.